Biochem/physiol Actions
VPC 01091 is a selective sphingosine 1-phosphate receptor-1 (S1PR1) agonist and sphingosine 1-phosphate receptor-3 (S1PR3) antagonist. It confers protection against lung injury and dysfunction after ischemia-reperfusion (IR) in mice.
General description
This product is covered by Patent Number US 7,754,703. Avanti manufactures this under license from University of Virginia.
VPC 01091 is a sphingosine analog.
Packaging
5 mL Amber Glass Screw Cap Vial (857345P-1mg)
This product has met the following criteria to qualify for the following awards: